ProMIS Neurosciences (PMN) analyst forecast and price target
Analyst forecast
Consensus of 8 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Guggenheim | Maintained | Buy | $100.00 from $69.00 | Aug 14, 2026 |
| Guggenheim | Maintained | Buy | $69.00 from $35.00 | Jul 29, 2026 |
| Chardan Capital | Maintained | Buy | $33.00 from $20.00 | Jul 28, 2026 |
| Chardan Capital | Initiated Coverage | Buy | $20.00 | Jul 27, 2026 |
| Roth Capital | Initiated Coverage | Buy | $19.00 | Jul 8, 2026 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | — | Jun 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Jun 24, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Jun 8, 2026 |
| Guggenheim | Maintained | Buy | $35.00 from $125.00 | Feb 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 from $4.00 | Dec 1, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Nov 21, 2025 |
| Guggenheim | Maintained | Buy | $5.00 from $6.00 | Nov 18, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $4.00 | Jul 14, 2025 |
| Maxim Group | Initiated Coverage | Buy | $3.00 | May 12, 2025 |
| Guggenheim | Maintained | Buy | — | Feb 26, 2025 |
| BTIG | Initiated Coverage | Buy | $8.00 | Oct 3, 2023 |
Frequently asked questions
What is the price target for PMN stock?
The average 12-month analyst price target for ProMIS Neurosciences (PMN) is $42.50, with a high estimate of $100.00 and a low of $18.00, across 4 analysts.
Is PMN a buy, sell, or hold?
Analysts covering ProMIS Neurosciences currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for PMN?
The average price target of $42.50 implies 213.19% upside from the last price of $13.57.
What is the latest analyst rating on PMN?
On Aug 14, 2026, Guggenheim maintained ProMIS Neurosciences at Buy with a price target of $100.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.